Researcher.Life Logo

Gynecological Endocrinology : Impact Factor & More

eISSN: 1473-0766pISSN: 0951-3590

Key Metrics

CiteScore
3.9
H-Index
69
Impact Factor
< 5
SJR
Q2Endocrinology
SNIP
0.82
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Gynecological Endocrinology

Gynecological Endocrinology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1987
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Gynecological Endocrinology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Gynecological Endocrinology

Iatrogenic menopause and long-term health: a call for better evidence
  • 31 Dec 2026
  • Gynecological Endocrinology
The estrobolome and its emerging role in endometriosis pathogenesis: no guts, no story?
  • 31 Dec 2026
  • Gynecological Endocrinology
Relugolix combination therapy in symptomatic adenomyosis and uterine fibroids: a case series
  • 31 Dec 2026
  • Gynecological Endocrinology
Multidimensional health evaluation in mid-aged women: cross-sectional study protocol for a future-implementable program
  • 31 Dec 2026
  • Gynecological Endocrinology
Outcome comparisons of controlled ovarian hyperstimulation protocols in adenomyosis patients: a real-world retrospective cohort study
  • 31 Dec 2026
  • Gynecological Endocrinology
Bushen Huatan formula improves reproductive and endocrine metabolic disorders in non-obese polycystic ovary syndrome rats via adipose tissue-derived exosomal miR-27a-3p/PPARG signaling pathway
  • 31 Dec 2026
  • Gynecological Endocrinology
Iatrogenic menopause and long-term health: a call for better evidence
  • 31 Dec 2026
  • Gynecological Endocrinology
The estrobolome and its emerging role in endometriosis pathogenesis: no guts, no story?
  • 31 Dec 2026
  • Gynecological Endocrinology
Relugolix combination therapy in symptomatic adenomyosis and uterine fibroids: a case series
  • 31 Dec 2026
  • Gynecological Endocrinology
Multidimensional health evaluation in mid-aged women: cross-sectional study protocol for a future-implementable program
  • 31 Dec 2026
  • Gynecological Endocrinology
Outcome comparisons of controlled ovarian hyperstimulation protocols in adenomyosis patients: a real-world retrospective cohort study
  • 31 Dec 2026
  • Gynecological Endocrinology
Bushen Huatan formula improves reproductive and endocrine metabolic disorders in non-obese polycystic ovary syndrome rats via adipose tissue-derived exosomal miR-27a-3p/PPARG signaling pathway
  • 31 Dec 2026
  • Gynecological Endocrinology

FAQs on Gynecological Endocrinology